Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane W Goodwin

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Lancet. Gastroenterology & Hepatology|November 28, 2025
Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel diseaseMohammad Shebab, Ahmed Al-Hindawi, Shane W Goodwin, et al.
Epilepsy & Behavior : E&B|January 31, 2020
Validation of the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55 and QOLCE-16) for use by parents of young adults with childhood-onset epilepsyKlajdi Puka, Shane W Goodwin, Mark A Ferro, et al.
The American Journal of Gastroenterology|April 3, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 TrialShane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano, et al.
Journal of Crohn'S & Colitis|June 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trialsShane W Goodwin, Yuhong Yuan, Siddharth Singh, et al.
The American Journal of Gastroenterology|October 22, 2025
Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based StudyDhruv Ahuja, Claudia Dziegielewski, Kuan-Hung Yeh, et al.
Inflammatory Bowel Diseases|July 3, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing aloneSudheer Kumar Vuyyuru, Shane W Goodwin, Virginia Solitano, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Treatment and Outcomes of Crohn's Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23Dhruv Ahuja, Soo-Kyung Park, Yuchen Qi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Lancet. Gastroenterology & Hepatology|November 28, 2025
Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel diseaseMohammad Shebab, Ahmed Al-Hindawi, Shane W Goodwin, et al.
Epilepsy & Behavior : E&B|January 31, 2020
Validation of the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55 and QOLCE-16) for use by parents of young adults with childhood-onset epilepsyKlajdi Puka, Shane W Goodwin, Mark A Ferro, et al.
The American Journal of Gastroenterology|April 3, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 TrialShane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano, et al.
Journal of Crohn'S & Colitis|June 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trialsShane W Goodwin, Yuhong Yuan, Siddharth Singh, et al.
The American Journal of Gastroenterology|October 22, 2025
Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based StudyDhruv Ahuja, Claudia Dziegielewski, Kuan-Hung Yeh, et al.
Inflammatory Bowel Diseases|July 3, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing aloneSudheer Kumar Vuyyuru, Shane W Goodwin, Virginia Solitano, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Treatment and Outcomes of Crohn's Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23Dhruv Ahuja, Soo-Kyung Park, Yuchen Qi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel, et al.
Pageof 3